PAUL C GRINT Insider Trading
Get free email notifications about insider trading for PAUL C GRINT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL C GRINT. PAUL C GRINT is an Chief Executive Officer in AmpliPhi Biosciences Corp ($APHB) and a Director in AmpliPhi Biosciences Corp ($APHB) and a Director in ILLUMINA INC ($ILMN) and a President & CEO in Regulus Therapeutics Inc. ($RGLS) and a Director in Inhibikase Therapeutics, Inc. ($IKT).
Address: 3030 CALLAN RD SAN DIEGO 92121 CA
Companies in which PAUL C GRINT is an Insider
Armata Pharmaceuticals, Inc.
Trading Symbol: APHBIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL C GRINT: Chief Executive Officer, Director
Holdings: 599 shares
Current Value: $323
Latest Transaction: Dec 12 2017
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ILLUMINA, INC.
Trading Symbol: ILMNIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of PAUL C GRINT: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 14 2005
$ILMN Market Capitalization: $23.92B
$ILMN Previous Close: $162.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inhibikase Therapeutics, Inc.
Trading Symbol: IKTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL C GRINT: Director
Holdings: 0 shares
Latest Transaction: Jun 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Trading Symbol: RGLSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL C GRINT: President & CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2017
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL C GRINT
Sentiment: All, APHB, ILMN, IKT, RGLS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2021 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 2.92 | 22,677 | 66,217 | 22,677 | |
Dec 29 2020 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
Dec 29 2020 | IKT | Inhibikase Therape ... | GRINT PAUL C | Director | Option Exercise | A | 10.00 | 6,825 | 68,250 | 6,825 | |
Dec 12 2017 | APHB | AmpliPhi Bioscienc ... | GRINT PAUL C | Chief Executive Off ... | Grant | A | 0.62 | 599 | 371 | 599 | 0 to 599 |
Sep 11 2017 | APHB | AmpliPhi Bioscienc ... | GRINT PAUL C | Chief Executive Off ... | Option Exercise | A | 0.91 | 285,113 | 259,453 | 285,113 | |
Sep 11 2017 | APHB | AmpliPhi Bioscienc ... | GRINT PAUL C | Chief Executive Off ... | Option Exercise | A | 0.91 | 190,076 | 172,969 | 190,076 | |
Feb 23 2017 | RGLS | Regulus Therapeuti ... | GRINT PAUL C | President & CEO | Option Exercise | A | 1.20 | 410,000 | 492,000 | 410,000 |